摘要 |
The present invention is directed to compounds that are inhibitors of cysteine protease, in particular, cathepsins B, K, L, F, and S and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceutical compositions comprising these compounds and processes for preparing them.
|
申请人 |
AXYS PHARMACEUTICALS, INC.;GRAUPE, MICHAEL;LAU, AGNES;LINK, JOHN O.;LIU, YANG;MOSSMAN, CRAIG J.;PATTERSON, JOHN W.;ZIPFEL, SHEILA M. |
发明人 |
GRAUPE, MICHAEL;LAU, AGNES;LINK, JOHN O.;LIU, YANG;MOSSMAN, CRAIG J.;PATTERSON, JOHN W.;ZIPFEL, SHEILA M. |